This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

MedTech Summit
Hybrid Event, 20 - 24 June 2022
In-Person: Clayton Hotel Burlington Road, Dublin, IrelandDigital Experience: One track will be live-streamed each day in BST time zone, with on-demand recording access for all other tracks made available from the afternoon of the following day. Learn more on the Digital Experience page.

Crystal D’Silva, ERT
Research Scientist at Baxter


Crystal D’Silva is a Biocompatibility subject matter expert at Baxter International and based in Brussels, Belgium. Currently, she acts as preclinical lead for Baxter’s acute renal and nutrition product portfolios where she engages with a cross-functional team of internal and external stakeholders to conduct biological risk evaluations according to global guidelines. Additionally, she co-chairs an internal task force with a focus on hemocompatibility, in vitro toxicology, and the dissemination of lessons learned from regulatory submissions. She is actively involved in standard development as a member of the ISO/TC 194 biological and clinical evaluation of medical devices technical committee and she is also a member of the European society of toxicology in vitro (ESTIV) and the Belgian society of toxicology and ecotoxicology (BELTOX). She has a PhD in Medical Biophysics from the University of Toronto in collaboration with the Princess Margaret Cancer Centre and the Hospital for Sick Children (Ontario, Canada), and an MSc in Pathology and Molecular Medicine from Queen’s University (Ontario, Canada)

Agenda Sessions

  • Chairperson Afternoon Remarks

  • Panel: The Impact of the ISO 10993-1 Revision on Industry

  • Case Study: In Vitro Hemocompatibility Testing of Medical Devices